Germany’s largest biomedical research institute foster the use of Phase Holographic Imaging technology
German Cancer Research Center (DKFZ) in Heidelberg and Phase Holographic Imaging have signed a collaboration agreement, to foster the use of HoloMonitor technology at DKFZ. A HoloMonitor M4 with a motorized XY-stage will be centrally installed at the Imaging and Cytometry Core Facility and made available to the over 1 000 cancer researchers at DKFZ.
“DKFZ is one of the leading cancer research centers in Europe, if not the leading. Our strategy is to continue to demonstrate the benefits of HoloMonitor technology with leading research institutions and key opinion leaders on the forefront of cancer research. A key goal for PHI is to establish 8 strategic partnerships with leading research institutions before the end of 2015. With this agreement, 6 such agreements have now been signed”, says CEO Peter Egelberg.
Links
- German Cancer Research Center – www.dkfz.de
For additional information, please contact:
Peter Egelberg, CEO
Tel: +46 703 19 42 74
E-mail: peter.egelberg@phiab.se
Web: www.phiab.se
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.
Tags: